Sunday, June 21, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 446 of 1,261

  1. US 10543282

    Targeted peptide conjugates

    Marker Gene Technologies, Inc · Granted Jan 28, 2020 · Expires Jan 23, 2040

    granted

  2. US 10543222

    Therapy for inhibition of single-stranded RNA virus replication

    RedHill Biopharma Ltd. · Granted Jan 28, 2020 · Expires Jan 23, 2040

    granted

  3. US 10543181

    Toxic aldehyde related diseases and treatment

    Aldeyra Therapeutics, Inc. · Granted Jan 28, 2020 · Expires Jan 23, 2040

    granted

  4. US 10543192

    Glycopyrrolate salts

    Dermira, Inc. · Granted Jan 28, 2020 · Expires Jan 23, 2040

    granted

  5. US 10543190

    Suppositories comprising cannabinoids

    AXIM BIOTECHNOLOGIES. INC. · Granted Jan 28, 2020 · Expires Jan 23, 2040

    granted

  6. US 10543237

    Bioeffective krill oil compositions

    AKER BIOMARINE ANTARCTIC AS · Granted Jan 28, 2020 · Expires Jan 23, 2040

    granted

  7. US 10544467

    Solid tumor methylation markers and uses thereof

    The Regents of the University of California · Granted Jan 28, 2020 · Expires Jan 23, 2040

    granted

  8. US 10544418

    RNAi inhibition of alpha-ENaC expression

    Arrowhead Pharmaceuticals, Inc. · Granted Jan 28, 2020 · Expires Jan 23, 2040

    granted

  9. US 10543257

    Lentiviral vector for treating hemoglobin disorders

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jan 28, 2020 · Expires Jan 23, 2040

    granted

  10. US 10544406

    Characterization of four prophage endolysins specific for clostridium perfringens

    The United States of America, as represented by the Secretary of Agriculture · Granted Jan 28, 2020 · Expires Jan 23, 2040

    granted

  11. US 10544392

    Methods of isolating T cells and T cell receptors having antigenic specificity for a cancer-specific mutation from peripheral blood

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jan 28, 2020 · Expires Jan 23, 2040

    granted

  12. US 10544223

    Combination therapy with an anti-axl antibody-drug conjugate

    ADC THERAPEUTICS SA · Granted Jan 28, 2020 · Expires Jan 23, 2040

    granted

  13. US 10544232

    Methods for treating patients with heterozygous familial hypercholesterolemia (heFH) with an anti-PCSK9 antibody

    REGENERON PHARMACEUTICALS, INC. · Granted Jan 28, 2020 · Expires Jan 23, 2040

    granted

  14. US 10544199

    Interferon alpha 2B variants

    TEVA PHARMACEUTICALS AUSTRALIA PTY LTD · Granted Jan 28, 2020 · Expires Jan 23, 2040

    granted

  15. US 10543280

    Stabilization of biomolecules using sugar polymers

    The Regents of the University of California · Granted Jan 28, 2020 · Expires Jan 23, 2040

    granted

  16. US 10543337

    Nitric oxide delivery devices

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Jan 28, 2020 · Expires Jan 23, 2040

    granted

  17. US 10544145

    P2X3 and/or P2X2/3 compounds and methods

    Asana BioSciences, LLC · Granted Jan 28, 2020 · Expires Jan 23, 2040

    granted

  18. US 10544111

    Heterocyclic compound

    Takeda Pharmaceutical Company Limited · Granted Jan 28, 2020 · Expires Jan 23, 2040

    granted

  19. US 10544113

    Thiazolidinone compounds and use thereof

    Regents of the University of Minnesota · Granted Jan 28, 2020 · Expires Jan 23, 2040

    granted

  20. US 10544085

    Oils having antibacterial activity

    The United States of America, as represented by the Secretary of Agriculture · Granted Jan 28, 2020 · Expires Jan 23, 2040

    granted

  21. US 10543481

    Targeted, metal-catalyzed fluorination of complex compounds with fluoride ion via decarboxylation

    THE TRUSTEES OF PRINCETON UNIVERSITY · Granted Jan 28, 2020 · Expires Jan 23, 2040

    granted

  22. US 10543283

    Intranasal administration of guanidinylated aminoglycosides

    The Regents of the University of California · Granted Jan 28, 2020 · Expires Jan 23, 2040

    granted

  23. US 2020024256

    TETRAHYDRATE OF H3 LIGAND, ITS PROCESS OF PREPARATION AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME

    BIOPROJET PHARMA [FR] · Granted Jan 23, 2020 · Expires Jan 18, 2040

    granted

  24. US 10538590

    Photosensitizing antibody-fluorophore conjugates

    The United States of America as Represented by the Secretary, Dept. of Health and Human Services · Granted Jan 21, 2020 · Expires Jan 16, 2040

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.